MCC Activators encompass a distinct group of chemical entities that have the ability to modulate the activity of the protein known as MCC, or Mitotic Checkpoint Complex. The Mitotic Checkpoint Complex is a key regulator of the spindle assembly checkpoint (SAC), a safety mechanism in cell division ensuring proper chromosome segregation and preventing aneuploidy. MCC functions by inhibiting the activity of the anaphase-promoting complex/cyclosome (APC/C), thus delaying the onset of anaphase until all chromosomes are properly attached to the spindle apparatus.
The mode of action through which MCC Activators exert their influence can be multifaceted. They may directly bind to the protein and alter its configuration, thereby potentiating its ability to inhibit APC/C and enhance the SAC function. Alternatively, these activators could impact the protein indirectly, possibly by influencing the signaling pathways that regulate the formation of the MCC or its binding to APC/C. This could involve altering the phosphorylation state of components of the MCC or other upstream regulators that modulate its assembly and activity. Given the crucial role of MCC in cell cycle regulation, the study of MCC Activators is significant in the field of cellular biology and understanding the precise mechanisms governing cell division. Activation of MCC can lead to a sustained mitotic arrest, providing a window into the complex orchestration of molecular interactions required for accurate chromosome segregation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin enhances MCC activity by increasing cAMP levels. Elevated cAMP activates protein kinase A (PKA), which phosphorylates and activates MCC. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, leading to an increase in cAMP levels, which subsequently activates PKA. The activated PKA phosphorylates and activates MCC. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a phosphodiesterase inhibitor, increases cAMP levels, which activate PKA. The activated PKA then phosphorylates and activates MCC. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to beta-adrenergic receptors, leading to an increase in intracellular cAMP levels. The increased cAMP activates PKA, which phosphorylates and activates MCC. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide inhibits phosphodiesterase 3, leading to increased cAMP levels. The increased cAMP activates PKA, which then phosphorylates and activates MCC. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A, preventing dephosphorylation of MCC, thus maintaining MCC in its activated state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases PP1 and PP2A, preventing dephosphorylation of MCC, thus maintaining MCC in its activated state. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin inhibits protein phosphatases PP1 and PP2A, preventing dephosphorylation of MCC, thus maintaining MCC in its activated state. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Endothall inhibits protein phosphatases PP1 and PP2A, preventing dephosphorylation of MCC, thus maintaining MCC in its activated state. | ||||||